MEK INHIBITOR-ASSOCIATED SEROUS RETINOPATHY

This adverse event was reported 4 times

These drugs are most commonly taken by patients reporting MEK INHIBITOR-ASSOCIATED SEROUS RETINOPATHY:

# Drug Count
0 COBIMETINIB 2
1 TRAMETINIB 2
2 VEMURAFENIB 2
3 CIPROFLOXACIN 1
4 CIPROFLOXACIN HYDROCHLORIDE 1
5 CIPROFLOXACIN TABLETS 1
6 CIPROFOLXACIN 1
7 DABRAFENIB 1
8 HYDROCHLOROTHIAZIDE 1
9 METFORMIN 1
See all common drugs associated with MEK INHIBITOR-ASSOCIATED SEROUS RETINOPATHY

MEK INHIBITOR-ASSOCIATED SEROUS RETINOPATHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 COBIMETINIB 2 0.0005
1 VEMURAFENIB 2 0.0002
2 TRAMETINIB 2 0.0001
3 DABRAFENIB 1 0.0000
4 CIPROFLOXACIN TABLETS 1 0.0000
5 CIPROFLOXACIN HYDROCHLORIDE 1 0.0000
6 HYDROCHLOROTHIAZIDE 1 0.0000
7 METFORMIN ER 500 MG 1 0.0000
8 PREDNISONE 1 0.0000
See all drugs enriched for association with MEK INHIBITOR-ASSOCIATED SEROUS RETINOPATHY

These drug classes are most commonly taken by patients reporting MEK INHIBITOR-ASSOCIATED SEROUS RETINOPATHY:

# Drug class Count
0 Kinase Inhibitor [EPC] 2
1 Corticosteroid [EPC] 1
2 Fluoroquinolone Antibacterial [EPC] 1
3 Thiazide Diuretic [EPC] 1
See all common drug classes associated with MEK INHIBITOR-ASSOCIATED SEROUS RETINOPATHY

MEK INHIBITOR-ASSOCIATED SEROUS RETINOPATHY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Fluoroquinolone Antibacterial [EPC] 1 0.0000
1 Thiazide Diuretic [EPC] 1 0.0000
2 Kinase Inhibitor [EPC] 2 0.0000
3 Corticosteroid [EPC] 1 0.0000
See all drug classes enriched for association with MEK INHIBITOR-ASSOCIATED SEROUS RETINOPATHY